Q32 Bio Inc. (QTTB) Total liabilities 2018–2025
Q32 Bio Inc. (QTTB) total liabilities at each fiscal year-end, per SEC filings.
$19.8MFY2025 · since FY2018: $62.7M → $19.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.8M | -77.2% |
| FY2024 | $86.7M | -26.9% |
| FY2023 | $118.5M | +134.8% |
| FY2022 | $50.5M | +20.0% |
| FY2021 | $42.1M | -37.9% |
| FY2020 | $67.7M | +30.1% |
| FY2019 | $52.1M | -17.0% |
| FY2018 | $62.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Operating cash flowQTTB Free cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Shareholders’ equityQTTB overview →